FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/044539 [Registered on: 01/08/2022] Trial Registered Prospectively
Last Modified On: 01/07/2022
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Ultrasound of Diaphragm in Guillain-Barre Syndrome patients 
Scientific Title of Study   Ultrasonographic Assessment of Diaphragmatic Function in Guillain-Barre Syndrome patients admitted to the intensive care unit 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rajeeb Kumar Mishra 
Designation  Assistant Professor 
Affiliation  National Institute of Mental Health and Neurosciences 
Address  Department of Neuroanaesthesia and Neurocritical care, NIMHANS

Bangalore
KARNATAKA
560029
India 
Phone  09968961339  
Fax    
Email  litu86@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rajeeb Kumar Mishra 
Designation  Assistant Professor 
Affiliation  National Institute of Mental Health and Neurosciences 
Address  Department of Neuroanaesthesia and Neurocritical care, NIMHANS

Bangalore
KARNATAKA
560029
India 
Phone  09968961339  
Fax    
Email  litu86@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rajeeb Kumar Mishra 
Designation  Assistant Professor 
Affiliation  National Institute of Mental Health and Neurosciences 
Address  Department of Neuroanaesthesia and Neurocritical care, NIMHANS

Bangalore
KARNATAKA
560029
India 
Phone  09968961339  
Fax    
Email  litu86@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Mental Health and Neurosciences Hosur Road, Near Bangalore Milk Dairy, Bengluru, Karnataka - 560029 
 
Primary Sponsor  
Name  National Institute of Mental Health and Neurosciences 
Address  Hosur Road, Near Bangalore Milk Dairy, Bengluru, Karnataka - 560029 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Rajeeb Kumar Mishra  Neurocritical care Units of NIMHANS  Department of Neuroanaesthesia and Neurocritical care, NIMHANS
Bangalore
KARNATAKA 
9968961339

litu86@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
NIMHANS IEC BS AND NS DIV  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G610||Guillain-Barre syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  • Patients aged 18 to 70 years, fulfilling the National Institute of Neurological Disorders and Stroke (NINDS) criteria for GBS and Brighton level of certainty of diagnosis of one or two.
• Patients requiring ICU admission
 
 
ExclusionCriteria 
Details  • Refusal of consent
• Patients with cardiac failure, renal or liver failure
• Preexisting uni- or bilateral diaphragmatic paralysis
• Severe sepsis with inotropic support  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
• To estimate the diaphragm thickness, DTF, excursion, and velocity of contraction measured by ultrasound at ICU admission in patients with GBS requiring tracheal intubation and MV  At the admission to ICU or initiation of mechanical ventilation (baseline),
thereafter weekly once for a maximum of 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To determine the effect of changes in diaphragm measurements by ultrasound on the weaning success.  At the time of first weaning trial (5 min after disconnection from ventilator and then 30 min after disconnection) 
To determine the effect of baseline diaphragm parameters by ultrasound on the duration of MV and ICU stay.  Baseline values  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIMS AND OBJECTIVES

The purpose of this study is to assess serial changes in diaphragm function of GBS patients measured by ultrasonography during their course in the ICU and assess its usefulness in predicting the weaning success.

 

PRIMARY OBJECTIVES

  • To estimate the diaphragm thickness, DTF, excursion, and velocity of contraction measured by ultrasound at ICU admission in patients with GBS requiring tracheal intubation and MV

 

SECONDARY OBJECTIVES

  • To determine the effect of changes in diaphragm measurements by ultrasound on the weaning success.
  • To determine the effect of baseline diaphragm parameters by ultrasound on the duration of MV and ICU stay.

 

METHODOLOGY

Study design: A prospective, observational cohort study 

Study site: Neuro ICUs of National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru 

Duration of study: 24 months 

Expected sample size:  All consequent patients meeting inclusion criteria will be recruited during the study period. We expect an annual admission of 30 to 40 patients with GBS to ICU during the study period.

 Inclusion Criteria

·      Patients aged 18 to 70 years, fulfilling the National Institute of Neurological Disorders and Stroke (NINDS) criteria for GBS and Brighton level of certainty of diagnosis of one or two.

·      Patients requiring ICU admission

Exclusion Criteria

  • Refusal of consent
  • Patients with cardiac failure, renal or liver failure 
  • Preexisting uni- or bilateral diaphragmatic paralysis
  • Severe sepsis with inotropic support 

 

STUDY PROTOCOL

This study will be a prospective observational study done in patients with GBS admitted to Neuro ICUs at NIMHANS. The institutional ethical committee approval and informed consent from the patient’s guardian will be obtained before recruiting patients. All patients will be managed using standard practice guidelines with plasmapheresis or intravenous immunoglobulins based on the feasibility with a multidisciplinary team involving a neurologist and intensivist on admission to the ICU. Demographic details such as gender, age on admission, underlying co-morbidities, reasons for tracheal intubation, and duration of MV will be recorded. The right hemidiaphragm will be assessed ultrasonographically, and the following parameters: DTF, diaphragm thickness (DT), diaphragmatic excursion (DE), and peak velocity of the diaphragm during cough expiration will be recorded. Ultrasonographic assessment of the diaphragm will be done on day-1 of ICU admission. If the patient needs MV, then another set of diaphragm assessments will be carried out after the initiation of MV. A subsequent assessment will be done once a week until the patient is successfully weaned off the ventilator. In mechanically ventilated patients, all measurements will be performed in the semirecumbent position and connected to the ventilator in pressure support mode with a pressure support setting of 8-10 cmH2O and physiological (0-5 cmH2O) positive end-expiratory pressure. Diaphragmatic assessment will also be done during the first spontaneous breathing trial (SBT) of 30 minutes. Patients will be disconnected from the ventilator. The first diaphragmatic assessment will be done 5 minutes after disconnection and later at the end of the 30 minutes before connecting back to the ventilator. Successful weaning will be defined as the ability to maintain spontaneous breathing without ventilatory support for > 24 hours. The time taken for successful weaning from initiation of 1st SBT of 30 minutes will be noted. We will monitor the diaphragmatic parameters till a mximum period of 8 weeks from the ICU admission. In our ICU the duration of stay of GBS patients range from 9-45 days in the last six months. Patinets who require very prolonged ICU stay (beyond 8 weeks) will be excluded from the analysis due to deficient follow up ultrasonographic scans for the diaphragmatic function.

 
Close